日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors

更正:膜相关癌-卵母细胞新抗原SAS1B/卵黄素是子宫肿瘤的候选免疫治疗靶点。

Pires, Eusebio S; D'Souza, Ryan S; Needham, Marisa A; Herr, Austin K; Jazaeri, Amir A; Li, Hui; Stoler, Mark H; Anderson-Knapp, Kiley L; Thomas, Theodore; Mandal, Arabinda; Gougeon, Alain; Flickinger, Charles J; Bruns, David E; Pollok, Brian A; Herr, John C

Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors

膜相关癌-卵母细胞新抗原SAS1B/卵黄素是子宫肿瘤的候选免疫治疗靶点。

Pires, Eusebio S; D'Souza, Ryan S; Needham, Marisa A; Herr, Austin K; Jazaeri, Amir A; Li, Hui; Stoler, Mark H; Anderson-Knapp, Kiley L; Thomas, Theodore; Mandal, Arabinda; Gougeon, Alain; Flickinger, Charles J; Bruns, David E; Pollok, Brian A; Herr, John C